Dalbergin (6-Hydroxy-7-Methoxy-4-Phenylcoumarin) is a research compound with potential anti-osteoporotic activity, demonstrating bone-conserving effects comparable to estradiol in models of postmenopausal bone loss. It also shows promise in dermatological research for mitigating photoaging by regulating extracellular matrix degradation.
